España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ATAI Life Sciences
ATAI
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.61
0.24
17.52%
At close: -
$1.60
-0.01
-0.62%
After Hours: Nov 15, 7:59 PM EDT
Get Report
Comment
Q3 2024 Earnings were released on Wed Nov 13th, before the market open
ATAI Life Sciences (ATAI) Forecast
News
Earnings
ATAI Life Sciences (ATAI) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ATAI Life Sciences (NASDAQ:ATAI) Stock
ATAI Life Sciences Stock (NASDAQ: ATAI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 13, 2024
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
Juan Spínelli
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
Juan Spínelli
ATAI Life Sciences Q3 EPS $(0.16), Inline, Sa...
Benzinga Newsdesk
Monday, October 07, 2024
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
Juan Spínelli
Friday, October 04, 2024
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
Juan Spínelli
Friday, September 13, 2024
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
Juan Spínelli
Thursday, September 05, 2024
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
Juan Spínelli
Friday, August 30, 2024
HC Wainwright & Co. Reiterates Buy on ATAI Li...
Benzinga Newsdesk
Wednesday, August 14, 2024
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
Juan Spínelli
Tuesday, August 13, 2024
atai Life Sciences Expects Cash, Marketable S...
Benzinga Newsdesk
atai Life Sciences Q2 EPS $(0.36), Down From ...
Benzinga Newsdesk
Wednesday, July 31, 2024
HC Wainwright & Co. Reiterates Buy on ATAI Li...
Benzinga Newsdesk
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
Javier Hasse
Friday, June 21, 2024
Cantor Fitzgerald Reiterates Overweight on AT...
Benzinga Newsdesk
Thursday, June 20, 2024
Atai Life Sciences Announced An Update On Bec...
Benzinga Newsdesk
Wednesday, June 05, 2024
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
Aaron Bry
What's Going On With MindMed And Psychedelic Stocks?
Erica Kollmann
Shares of psychedelics companies are trading ...
Benzinga Newsdesk
Friday, May 17, 2024
HC Wainwright & Co. Reiterates Buy on ATAI Li...
Benzinga Newsdesk
Wednesday, May 15, 2024
ATAI Life Sciences Q1 EPS $(0.17) Beats $(0.1...
Benzinga Newsdesk
Thursday, May 09, 2024
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
Nina Zdinjak
Wednesday, April 24, 2024
Atai Life Sciences Disclosed Dosing Of First ...
Benzinga Newsdesk
Friday, April 19, 2024
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked'
Caleb Naysmith
Wednesday, April 17, 2024
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
Lara Goldstein
ATAI Life Sciences Announces the Publication ...
Benzinga Newsdesk
Thursday, April 04, 2024
Cantor Fitzgerald Reiterates Overweight on AT...
Benzinga Newsdesk
Wednesday, April 03, 2024
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
ATAI Life Sciences shares are trading higher ...
Benzinga Newsdesk
Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Maxim Group Upgrades ATAI Life Sciences to Bu...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on ATAI Lif...
Benzinga Newsdesk
Friday, March 29, 2024
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
Lara Goldstein
Thursday, March 28, 2024
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression
Lara Goldstein
ATAI Life Sciences shares are trading higher ...
Benzinga Newsdesk
Recap: ATAI Life Sciences Q4 Earnings
Benzinga Insights
ATAI Life Sciences Q4 EPS $(0.12) Beats $(0.1...
Benzinga Newsdesk
Wednesday, March 27, 2024
HC Wainwright & Co. Maintains Buy on ATAI Lif...
Benzinga Newsdesk
Wednesday, March 20, 2024
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
Lara Goldstein
Saturday, March 16, 2024
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Lara Goldstein
Thursday, March 14, 2024
Reported Earlier, 'Indiana Lawmakers Send Psi...
Benzinga Newsdesk
Thursday, March 07, 2024
ATAI Life Sciences shares are trading higher ...
Benzinga Newsdesk
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
atai Life Sciences Announces First Participan...
Benzinga Newsdesk
Thursday, February 15, 2024
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Lara Goldstein
Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More
Lara Goldstein
Tuesday, February 06, 2024
atai Life Sciences Appoints Anne Johnson As C...
Benzinga Newsdesk
Saturday, January 27, 2024
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
Lara Goldstein
Monday, January 15, 2024
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
Lara Goldstein
Friday, January 12, 2024
Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
Lara Goldstein
Show More